However, our finding of no association in one-, three-, six-, and 12-month mortality between GLP-1 RA users and non-users post-surgery suggests that mortality benefits may not be the same for adult CHD patients undergoing critical cardiac procedures such as CABG. Here, GLP1R is linked to coronary artery disorder.